Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Dear colleagues,

The Lymphoma Working Party of the EBMT is conducting a short online survey headed by Dr. Gloria Iacoboni & Dr. Pere Barba on the current practice patterns of the centers regarding holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting.

Management of patients with mantle cell lymphoma who are candidates for CAR T cell therapy is challenging. There is great variability across centers regarding how to approach the holding and bridging therapy, due to the lack of solid data supporting specific strategies in this setting. 

Thus, we are conducting a survey to assess the peri-CART practice patterns in mantle cell lymphoma across centers. The aim is to determine common strategies in the peri-CART patient management.

The survey is short, not taking more than 15 minutes to answer, and the information generated can be of great value to guide patient care and identify potential research gaps in the field.

The deadline for data completion is by June 21th  of 2024.

Feel free to reach out if you have any questions when you take the survey.